[IR] On September 28th, SCM Lifescience Inc. held an ‘online company briefing session’
SCM Lifesciences Inc. will hold a corporate meeting to present the results of the Phase 2a clinical trial for moderate to severe pancreatitis for institutional investors at the Conrad Hotel in Seoul on September 5th.
At this corporate meeting, which will be attended by 16 institutions, the introduction of the new CEO, the presentation of the results of the phase 2a clinical trial of moderate-severe pancreatitis, and the presentation of the phase 2b clinical plan will be held.
In addition, to deliver fair information to shareholders, the contents of the announcement at this corporate meeting will be shared on the SCM Lifescience official YouTube channel.
In the future, SCM Lifescience will always strive to provide transparent and accurate information delivery to protect the rights and interests of shareholders.